Eurointervention

Article	Citations
TAVR under 70: is age just a number?	244
International variation in modality and outcomes of left main revascularisation: does it really matter?	130
Double-tap to treat paravalvular leak in high-risk annuli	109
The conundrum of percutaneous coronary intervention without aspirin: a call for clarity	96
In search of the origin of the acronym TAVI	93
Should we routinely use ultrasound-guided transfemoral access for coronary procedures? High-quality evidence from an individual participant data meta-analysis	80
Safety of early hospital discharge following admission with ST-elevation myocardial infarction treated with percutaneous coronary intervention: a nationwide cohort study	79
Development and validation of a scoring system for predicting clinical coronary artery perforation during percutaneous coronary intervention of chronic total occlusions: the PROGRESS-CTO perforation s	71
Transcatheter left ventriculoplasty	62
Valve-in-valve transcatheter aortic valve implantation versus repeat surgical aortic valve replacement in patients with a failed aortic bioprosthesis	61
Recanalisation of coronary chronic total occlusions	59
Long-term outcomes of measured and predicted prosthesis-patient mismatch following transcatheter aortic valve replacement	53
Prognostic value of structural and functional coronary microvascular dysfunction in patients with non-obstructive coronary artery disease; from the multicentre international ILIAS registry	52
Transcatheter edge-to-edge repair with the PASCAL device for failed MitraClip procedure	51
Defer-based non-stenting: a promising approach for STEMI	49
Life expectancy of patients with a transcatheter aortic valve and the implications for long-term valve durability data collection	48
Incidence and mechanisms of bioprosthetic dysfunction after transcatheter implantation of a mechanically-expandable heart valve	46
Transcatheter edge-to-edge valve repair versus minimally invasive beating-heart surgery of the tricuspid valve: an observational study	44
   Atrial fibrillation and acute coronary syndrome 	43
Hybrid coronary revascularisation: the best or the worst of both worlds?	41
One-month DAPT after acute coronary syndrome: too short or not too short?	41
The “road travelled”: reflections on the transformation of information exchange in a digital age	41
Twelve-month outcomes of the LuX-Valve for transcatheter treatment of severe tricuspid regurgitation	37
Redo transcatheter mitral valve replacement in mitral annular calcification	36
Defining high bleeding risk in patients undergoing transcatheter aortic valve implantation: a VARC-HBR consensus document	36

A novel robotic radiation shielding device for interventional cardiology procedures	35
Invasive functional testing in the cath lab as a routine investigation in INOCA: pros and cons	34
Outcomes of newly diagnosed atrial fibrillation in patients with acute coronary syndromes	34
Impact of off-hours admissions in STEMI-related cardiogenic shock managed with microaxial flow pump – insights from J-PVAD	32
Geographical variations in left main coronary artery revascularisation: a prespecified analysis of the EXCEL trial	32
Outcomes and performance of the ACURATE neo2 transcatheter heart valve in clinical practice: one-yearresults of the ACURATE neo2 PMCF Study	31
A sham-controlled randomised trial of pulmonary artery denervation for Group 1 pulmonary arterial hypertension: one-year outcomes of the PADN-CFDA trial	31
Early outcomes of transcatheter versus surgical aortic valve implantation in patients with bicuspid aortic valve stenosis	30
Long-term risk of unplanned percutaneous coronary intervention after transcatheter aortic valve replacement	30
Chordal replacement and annuloplasty in one transfemoral device for degenerative mitral regurgitation	30
Clinical outcomes of the third-generation resorbable magnesium scaffold for coronary artery lesions: three-year results of the BIOMAG-I study	30
A novel three-dimensional imaging approach to evaluate coronary access before transcatheter aortic valve-in-valve implantation	29
Oesophageal and gastric injuries caused by transoesophageal probe manipulation in patients undergoing transcatheter edge-to-edge repair for tricuspid regurgitation	29
Prevalence and outcomes of stent thrombosis with in-stent calcified nodules: substudy from the REAL-ST registry	28
ACURATE neo2 versus SAPIEN 3 Ultra for transcatheter aortic valve implantation	28
Antithrombotic therapy for transcatheter structural heart intervention	27
Percutaneous versus surgical transaxillary access for transcatheter aortic valve replacement: a propensity-matched analysis of the US experience	26
Cerebral embolic protection during transcatheter heart interventions	25
Retrievable scaffold therapy before paclitaxel drug-coated balloon angioplasty in infrapopliteal arteries: one-year outcomes of the DEEPER OUS Study	25
Coronary lithotripsy for the treatment of underexpanded stents: the international multicentre CRUNCH registry	25
Thirty-day outcomes of the Cardioband tricuspid system for patients with symptomatic functional tricuspid regurgitation: The TriBAND study	24
A nationwide analysis of reperfusion therapies for pulmonary embolism in older patients with frailty	24
Shifting focus in bifurcations.	23
Early outcomes of transcatheter mitral valve replacement with the Tendyne system in severe mitral annular calcification	23
SYNTAXES, biomarkers and survival in complex coronary artery disease: the intervention of secondary prevention	22
Optical coherence tomography to visualise the endothelialisation of left atrial appendage occluders	22
Delayed hospitalisation for heart failure after transcatheter repair or medical treatment for secondary mitral regurgitation: a landmark analysis of the MITRA-FR trial	22
TAVI patients with bystander coronary artery disease should receive PCI: pros and cons	22
Procedural and early outcomes of transcatheter edge-to-edge mitral valve repair in very elderly patients	21
Prevention of left ventricular outflow tract obstruction in transapical mitral valve replacement: the MitraCut procedure	21
New-onset atrial fibrillation detected by ambulatory ECG monitoring after transcatheter aortic valve implantation	20
Is transcatheter aortic valve implantation safe in patients with left ventricular outflow tract calcification?	20
Determinants of adverse outcomes following patent foramen ovale closure in elderly patients	20
UNICA − a novel single-stent, double-valve, heterotopic, cross-caval approach for severe tricuspid insufficiency 	20
Carbon footprint of diagnostic coronary angiography	20
The ongoing conundrum of the best care for patients presenting with non-ST-segment elevation acute coronary syndrome	19
Ticagrelor-based antiplatelet therapy after percutaneous coronary intervention in chronic coronary syndrome	19
Predictors and clinical impact of worsening left ventricular ejection fraction after mitral transcatheter edge-to-edge repair	19
Coronary CT as a first-line investigation in chronic coronary syndromes: pros and cons	19
Robotics, imaging, and artificial intelligence in the catheterisation laboratory	19
FFRangio-guided versus pressure wire-guided PCI: design and rationale of the multicentre, randomised ALL-RISE trial	19
Changes in non-culprit coronary lesions with PCSK9 inhibitors: the randomised, placebo-controlled FITTER trial	19
The patent foramen ovale does not spontaneously close in patients aged 60	19
Near-infrared spectroscopy to predict plaque progression in plaque-free artery regions	18
Three-year outcomes of transcatheter aortic valve implantation for bicuspid versus tricuspid aortic stenosis	18
Targeting inflammation in atherosclerosis: overview, strategy and directions	18
Diagnostic accuracy of quantitative flow ratio in patients with arrhythmias	18
Bioprosthetic valve fracture: haemodynamically effective but safe and clinically necessary?	18
Comparison of different percutaneous revascularisation timing strategies in patients undergoing transcatheter aortic valve implantation	18
Anterior mitral leaflet modification with endoscopic scissors during Tendyne implantation	17

SAPIEN 3 Ultra: better sealing, reduced paravalvular leak and a move in the right direction?	17
Low-dose fibrinolysis during primary percutaneous intervention for preventing no-reflow: stepping back to move forward?	17
Stent underexpansion in the CRUNCH registry: worth cracking?	17
Impact of chronic kidney disease and diabetes on clinical outcomes in women undergoing PCI	16
Direct oral anticoagulants for ventricular thrombus resolution: pilot trials show reassuring efficacy and safety compared to warfarin	16
Left atrial appendage closure for thrombus trapping: the international, multicentre TRAPEUR registry	16
PCR London Valves - in person or online - an invaluable opportunity for exchange dedicated to advancing the treatment of valvular heart disease	15
Letter: Caffeine and fractional flow reserve overestimation: a word of caution	15
Clinical outcomes of transcatheter mitral valve replacement: two-year results of the CHOICE-MI Registry	15
Procedural considerations for transcatheter aortic valve-in-valve implantation in a degenerated ACURATE neo prosthesis	15
Predictors and prognostic relevance of tricuspid alterations in patients undergoing transcatheter edge-to-edge mitral valve repair	15
Transcatheter aortic valve implantation in degenerated surgical aortic valves	14
Vessel fractional flow reserve (vFFR) for the assessment of stenosis severity: the FAST II study	14
EuroIntervention: the 200th issue	14
We now have enough evidence to support systematic OCT in daily PCI practice: pros and cons	14
Combined functional and anatomical assessment of coronary stenosis by coronary CT angiography	14
Device-related thrombus following left atrial appendage occlusion	14
Direct oral anticoagulants or warfarin in patients with left ventricular thrombus after ST-elevation myocardial infarction: a pilot trial and a prespecified meta-analysis of randomised trials	13
Management of coronary artery disease in patients undergoing transcatheter aortic valve implantation. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interv	13
Skating on thin ice: searching for vulnerable plaques	12
Outcomes of isolated tricuspid valve replacement: a systematic review and meta-analysis of 5,316 patients from 35 studies	12
Sirolimus-eluting or everolimus-eluting stents for coronary artery disease: 5-year outcomes of the randomised BIOFLOW-IV trial	11
Transcatheter closure of atrial septal defect and patent foramen ovale with Carag bioresorbable septal occluder: first-in-man experience with 24-month follow-up	11
One-step anatomic and function testing by cardiac CT versus second-line functional testing in symptomatic patients with coronary artery stenosis: head-to-head comparison of CT-derived fractional flow	11
Bioabsorbable polymer drug-eluting stents with 4-month dual antiplatelet therapy versus durable polymer drug-eluting stents with 12-month dual antiplatelet therapy in patients with left main coronary	11
Leaflet modification techniques to mitigate coronary obstruction risk during transcatheter aortic valve implantation	11
Radiation protection for healthcare professionals working in catheterisation laboratories during pregnancy: a statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI)	11
Incidence and clinical impact of major bleeding following left atrial appendage occlusion: insights from the Amplatzer Amulet Observational Post-Market Study	11
Percutaneous Valvular and Structural Heart Disease Interventions.2024 Core Curriculum of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC in collaboration with	11
Changes in absolute coronary flow and microvascular resistance during exercise in patients with ANOCA	11
A comparison of simplified or conventional antithrombotic regimens after left atrial appendage closure in patients at high bleeding risk: the PLATEBRISK study	11
Letter: Complex PCI in severe aortic stenosis: high risk, low reward?	11
Safety and efficacy of ticagrelor monotherapy according to drug-eluting stent type: the TWILIGHT-STENT study	11
Transcatheter interventions for heart failure	10
Paravalvular regurgitation after transcatheter aortic valve replacement in intermediate-risk patients: a pooled PARTNER 2 study	10
SCAI/EAPCI/ACVC Expert Consensus Statement on Cardiogenic Shock in Women	10
Coronary access after transcatheter aortic valve replacement in bicuspid versus tricuspid aortic stenosis	9
First experience of left atrial appendage occlusion using a 3D mini transoesophageal echocardiographic probe with conscious sedation	9
Controlled antegrade and retrograde subintimal tracking (CART) for recanalisation of chronic total occlusions	9
Impact of mitral regurgitation aetiology on the outcomes of transcatheter aortic valve implantation	9
My stroke story	9
Coronary sinus reducer therapy for refractory angina: is it ready for prime time?	9
Temporal patterns, characteristics, and predictors of clinical outcomes in patients undergoing percutaneous coronary intervention for stent thrombosis	8
Understanding the past, getting prepared for the future. (Going from in vivo to in vitro to in silico)	8
“Lotus root”: a novel optical coherence tomography imaging pattern in spontaneous coronary artery dissection	8
Long-term clinical outcomes of everolimus-eluting bioresorbable scaffolds versus everolimus-eluting stents: final five-year results of the AIDA randomised clinical trial	8
Pulmonary artery denervation – the suspense continues?	8
Commissural alignment with the novel Hydra transcatheter heart valve during aortic valve replacement	8
A randomised controlled trial of the Cathpax AIR radioprotection cabin during cardiology procedures	8
Letter: When is the optimal time point for detecting malapposition in coronary bifurcation trials?	8
Timing of coronary angiography in patients with non-ST-elevation acute coronary syndrome: long-term clinical outcomes from the nationwide SWEDEHEART registry	7
Timing of bioprosthetic valve fracture in transcatheter valve-in-valve intervention: impact on valve durability and leaflet integrity	7
Changes in post-PCI optimisation strategies with post-procedural FFR followed by IVUS	7
Coronary artery cannulation after transcatheter aortic valve implantation	7
A deep learning algorithm for detecting acute myocardial infarction	7
Repeat transcatheter aortic valve implantation and implications for transcatheter heart valve performance: insights from bench testing	7
Thirty years of transradial coronary interventions	6
Impact of moderate or severe left ventricular outflow tract calcification on clinical outcomes of patients with severe aortic stenosis undergoing transcatheter aortic valve implantation with self- and	6
Outcomes by sex in the International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA) trial	6
Breaking down the barriers in the management of INOCA: how can we do better in the diagnosis of coronary vasomotor disorders?	6
Safety and efficiency of percutaneous coronary intervention using a standardised optical coherence tomography workflow	6
Radial wall strain: a novel angiographic measure of plaque composition and vulnerability	6
Transcatheter tricuspid interventions are performed too late: pros and cons	6
Robotic-assisted percutaneous coronary intervention: the future or the past?	6
Echocardiographic guidance in transcatheter structural cardiac interventions	6
Rotational atherectomy combined with cutting balloon to optimise stent expansion in calcified lesions: the ROTA-CUT randomised trial	5
TAVI at 20: how a crazy idea led to a clinical revolution	5
Treatment of coronary bifurcation lesions, part II: implanting two stents. The 16th expert consensus document of the European Bifurcation Club	5
Transseptal puncture: procedural guidance, challenging situations and management of complications	5
Scores and algorithms in CTO PCI: “PROGRESS” or an exercise in futility?	5
Microaxial flow pump for high-risk PCI: are we ready for the prime time?	5
Histological examination of renal nerve distribution, density, and function in humans	5
New-onset or newly detected atrial fibrillation after transcatheter aortic valve implantation?	5
Low-flow, low-gradient aortic stenosis: an understanding is still a long way off	5
Durability of transcatheter aortic valve implantation in bicuspid aortic valve stenosis: the last missing piece?	5
Coronary flow and resistance patterns indexed by subtended myocardial mass in coronary microvascular dysfunction	5
Embolisation of a prosthetic mitral valve fragment during valve-in-valve transcatheter mitral valve implantation	5
SESAME technique: septal scoring along the midline endocardium	4
The 17th expert consensus document of the European Bifurcation Club – techniques to preserve access to the side branch during stepwise provisional stenting	4
Five-year outcomes of mild paravalvular regurgitation after transcatheter aortic valve implantation	4

Outcomes of quantitative flow ratio-based percutaneous coronary intervention in an all-comers study	4
Dual-therapy CD34 antibody-covered sirolimus-eluting COMBO stents versus sirolimus-eluting Orsiro stents in patients treated with percutaneous coronary intervention: the three-year outcomes of the SOR	4
Treatment of patent foramen ovale	4
Ultrasound-guided femoral access in patients with vascular closure devices: a prespecified analysis of the randomised UNIVERSAL trial	4
ARC-HBR criteria and TAVR: not all high bleeding risk patients look alike	4
TAVI in asymptomatic patients with severe aortic stenosis: pros and cons	4
Routine cerebral embolic protection in transcatheter aortic valve implantation: rationale and design of the randomised British Heart Foundation PROTECT-TAVI trial	4
Reply: The time has come to use attitudinally appropriate terminology when describing cardiac anatomy	4
Periprocedural continuation versus interruption of oral anticoagulant drugs during transcatheter aortic valve implantation: rationale and design of the POPular PAUSE TAVI trial	4
Electrosurgical laceration and stabilisation of three clip devices (ELASTA-Clip) to enable transcatheter mitral valve implantation	4
Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension: a multicentre registry	4
Consider aspirin bridging for non-cardiac surgery in patients with coronary stents treated with oral anticoagulation monotherapy	4
Prasugrel monotherapy versus standard DAPT in STEMI patients with OCT-guided or angio-guided complete revascularisation: design and rationale of the randomised, multifactorial COMPARE STEMI ONE trial	4
Letter: Composite endpoints in clinical trials - simplicity or perfection?	3
Three-year outcomes of A Randomized Multicentre Trial Comparing Revascularization and Optimal Medical Therapy for Chronic Total Coronary Occlusions (EuroCTO)	3
Treatment of severe aortic valve regurgitation with the Trilogy TAVI system	3
Proximal optimisation technique versus final kissing balloon inflation in coronary bifurcation lesions: the randomised, multicentre PROPOT trial	3
Stop at the yellow light spot: in vivo detection of preclinical atherosclerosis	3
Transcatheter tricuspid valve repair/replacement should be offered to all patients with severe tricuspid regurgitation: pros and cons	3
Prognostic impact and clinical outcomes of coronary flow reserve and hyperaemic microvascular resistance	3
Cost-effectiveness of an FFR-guided strategy during STEMI – no rose without a thorn	3
Quantitative flow ratio versus fractional flow reserve for Heart Team decision-making in multivessel disease: the randomised, multicentre DECISION QFR trial	3
Prevalence, classification, and treatment of residual shunt after patent foramen ovale closure	3
Low urine pH: a new marker for contrast-associated acute kidney injury?	3
A comparison of risk prediction models for patients with acute coronary syndromes	3
Transcatheter aortic valve implantation of a novel system for severe pure native aortic regurgitation in a patient with an ascending aorta aneurysm	3
Prevalence, predictors, and outcomes of in-stent restenosis with calcified nodules	2
Ticagrelor monotherapy versus ticagrelor plus aspirin in patients with chronic coronary syndrome and high ischaemic risk: a post hoc analysis of the TWILIGHT trial	2
Economic evaluation of fractional flow reserve-guided versus angiography-guided multivessel revascularisation in ST-segment elevation myocardial infarction patients in the FLOWER-MI randomised trial	2
Temporal trends in clinical outcomes after percutaneous coronary intervention: a systematic review of 66,327 patients from 25 all-comers trials	2
Transcatheter edge-to-edge mitral valve repair in patients with mitral annulus calcification	2
A study of the novel SinoCrown system for transcatheter aortic valve implantation	2
Standardisation of techniques for bifurcation stenting optimisation: the journey continues	2
Prevalence and patterns of in-stent neoatherosclerosis in lower extremity artery disease	2
Letter: ORBITA-2 trial design and rationale: what causes angina after PCI?	2
Feasibility of redo-TAVI in the self-expanding ACURATE neo2 valve: a computed tomography study	2
VA-ECMO in cardiogenic shock: is the road closed or open?	2
Clinical outcomes of the ACURATE neo2 transcatheter heart valve: a prospective, multicentre, observational, post-market surveillance study	2
Phasic flow patterns of right versus left coronary arteries in patients undergoing clinical physiological assessment	2
PCI of bystander coronary artery lesions should be performed before TAVI: pros and cons	2
Intravascular ultrasound guidance for lower extremity arterial and venous interventions	2
TAVI in moderate aortic stenosis and heart failure: pros and cons	2
Catheter directed therapies: an option for elderly frail patients with pulmonary embolism requiring reperfusion	2
In search of the “IDEAL” left main coronary stent and DAPT regimen	2
Long-term outcomes of catheter-based intervention for clinically significant paravalvular leak	2
Mechanical thrombectomy for pulmonary embolism revisited: technological breakthrough or simple renovation?	2
Reply: Due to the lack of significant mortality benefits along with high procedural complication rates, percutaneous coronary intervention of chronic total occlusions should be discouraged	2
Balloon-expandable versus self-expanding stents in native coarctation of the aorta: three-year results of a randomised controlled trial 	2
A prospective, first-in-human use of the NeVa mechanical thrombectomy device for patients with acute coronary syndromes	2
Comprehensive diagnosis in chronic coronary syndromes combining angiography and intracoronary testing: the AID-ANGIO study	2
Polymer-free versus biodegradable-polymer drug-eluting stent in patients undergoing percutaneous coronary intervention: an assessor-blind, non-inferiority, randomised controlled trial	2
A bench study of balloon-expandable valves for the treatment of self-expanding valve failure	2
Transcatheter edge-to-edge repair of severe calcific mitral regurgitation facilitated by balloon lithotripsy	2
Valve-in-valve TAVI: the new standard therapy for failing bioprosthetic valves?	2
Reply: ORBITA-2 trial design and rationale: what causes angina after PCI?	2
First-in-human description of a novel transcatheter tricuspid valve prosthesis to preserve the asymmetric shape of the right ventricle	2
Letter: Pretreatment with unfractioned heparin in patients undergoing primary PCI: a standard of treatment together with DAPT?	2
Women and coronary artery disease: not just underrepresented and underdiagnosed, but also undertreated!	2
Impact of one-month DAPT followed by aspirin monotherapy in patients undergoing percutaneous coronary intervention according to clinical presentation: a post hoc analysis of the randomised One-Month D	2